» Articles » PMID: 25973328

Stem Cells for the Cell and Molecular Therapy of Type 1 Diabetes Mellitus (T1D): the Gap Between Dream and Reality

Overview
Journal Am J Stem Cells
Date 2015 May 15
PMID 25973328
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In spite of intense research, over the past 2-3 decades, targeted to validating methods for the cure of T1D, based on cell substitution therapy in the place of exogenously administered insulin injections, achievement of the final goal continues to remain out of reach. In fact, aside of very limited clinical success of the few clinical trials of pancreatic islet cell transplantation in totally immunosuppressed patients with T1D, the vast majority of these diabetic patients invariably is insulin-dependent. New advances for cell and molecular therapy for T1D, including use of stem cells, are reviewed and discussed in an attempt to clearly establish where we are and where are we may go for the final cure for T1DM.

Citing Articles

Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model.

Arjmand B, Goodarzi P, Aghayan H, Payab M, Rahim F, Alavi-Moghadam S Front Endocrinol (Lausanne). 2019; 10:761.

PMID: 31781036 PMC: 6856665. DOI: 10.3389/fendo.2019.00761.


Applications of stem cells and bioprinting for potential treatment of diabetes.

Kumar S, Delgado M, Mendez V, Joddar B World J Stem Cells. 2019; 11(1):13-32.

PMID: 30705712 PMC: 6354103. DOI: 10.4252/wjsc.v11.i1.13.


Adult muscle-derived stem cells engraft and differentiate into insulin-expressing cells in pancreatic islets of diabetic mice.

Mitutsova V, Yeo W, Davaze R, Franckhauser C, Hani E, Abdullah S Stem Cell Res Ther. 2017; 8(1):86.

PMID: 28420418 PMC: 5395782. DOI: 10.1186/s13287-017-0539-9.


Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential.

Rohban R, Pieber T Stem Cells Int. 2017; 2017:5173732.

PMID: 28286525 PMC: 5327785. DOI: 10.1155/2017/5173732.


Role of stem cells during diabetic liver injury.

Wan Y, Garner J, Wu N, Phillip L, Han Y, McDaniel K J Cell Mol Med. 2015; 20(2):195-203.

PMID: 26645107 PMC: 4727564. DOI: 10.1111/jcmm.12723.

References
1.
Ashcroft F, Rorsman P . Diabetes mellitus and the β cell: the last ten years. Cell. 2012; 148(6):1160-71. PMC: 5890906. DOI: 10.1016/j.cell.2012.02.010. View

2.
Weiss M, Medicetty S, Bledsoe A, Rachakatla R, Choi M, Merchav S . Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2005; 24(3):781-92. DOI: 10.1634/stemcells.2005-0330. View

3.
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K . Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903):945-9. PMC: 3987909. DOI: 10.1126/science.1162494. View

4.
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T . Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2007; 26(1):101-6. DOI: 10.1038/nbt1374. View

5.
Xu X, Browning V, Odorico J . Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech Dev. 2011; 128(7-10):412-27. PMC: 3225072. DOI: 10.1016/j.mod.2011.08.001. View